RoosterBio Names Life Science Industry Leader, Timothy M. Kelly, Ph.D., as New Chief Executive Officer October 5, 2021
RoosterBio Releases RoosterGEM™, Cell & Gene Therapy’s First Complete Transduction Medium May 20, 2021
RoosterBio Launches Next Generation EV Collection Media as Part of a Complete hMSC-EV Production System December 16, 2020
RoosterBio Collaborates with Sartorius to Expand Cell and Gene Therapy Manufacturing Platform Technology into South Korea December 2, 2020
RoosterBio Signs Cooperative Research and Development Agreement with The Geneva Foundation and the Uniformed Services University September 30, 2020
RoosterBio Launches a Closed System Extracellular Vesicle Collection Medium Enabling Scalable and Standardized cGMP Manufacturing May 21, 2020
RoosterBio Recognized by MTEC with a Multi-Institution Team “Prototype of the Year” Award to Accelerate Regenerative Medicine April 15, 2020
